ReP USP - Resultado da busca

Artigo de periodico
Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia (2017)
Furtado, Felipe Magalhães; Scheucher, Priscila Santos; Santana, Bárbara Amélia Aparecida; Zanette, Dalila Lucíola; Calado, Rodrigo Tocantins; Rego, Eduardo Magalhães; Matos, Daniel Mazza; Falcão, Roberto Passetto
Source: Revista Brasileira de Hematologia e Hemoterapia. Unidade: FMRP
Subjects: LEUCEMIA, MICRORNAS, CITOMETRIA DE FLUXO, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Felipe Magalhães et al. Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia. Revista Brasileira de Hematologia e Hemoterapia, v. 39, n. 3, p. 237-243, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.bjhh.2017.03.006. Acesso em: 25 abr. 2026.
APA
Furtado, F. M., Scheucher, P. S., Santana, B. A. A., Zanette, D. L., Calado, R. T., Rego, E. M., et al. (2017). Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia. Revista Brasileira de Hematologia e Hemoterapia, 39( 3), 237-243. doi:10.1016/j.bjhh.2017.03.006
NLM
Furtado FM, Scheucher PS, Santana BAA, Zanette DL, Calado RT, Rego EM, Matos DM, Falcão RP. Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39( 3): 237-243.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.bjhh.2017.03.006
Vancouver
Furtado FM, Scheucher PS, Santana BAA, Zanette DL, Calado RT, Rego EM, Matos DM, Falcão RP. Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39( 3): 237-243.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.bjhh.2017.03.006
Curadoria
Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - Hemo 2017 (2017)
Covas, Dimas Tadeu; Falcão, Roberto Passetto; Calado, Rodrigo; Simões, Belinda Pinto; Rego, Eduardo Magalhães; Traina, Fabiola; Tone, Luiz Gonzaga
Unidade: FMRP
Assunto: HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COVAS, Dimas Tadeu et al. Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - Hemo 2017. . Curitiba: ABHH. . Acesso em: 25 abr. 2026. , 2017
APA
Covas, D. T., Falcão, R. P., Calado, R., Simões, B. P., Rego, E. M., Traina, F., & Tone, L. G. (2017). Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - Hemo 2017. Curitiba: ABHH.
NLM
Covas DT, Falcão RP, Calado R, Simões BP, Rego EM, Traina F, Tone LG. Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - Hemo 2017. 2017 ;[citado 2026 abr. 25 ]
Vancouver
Covas DT, Falcão RP, Calado R, Simões BP, Rego EM, Traina F, Tone LG. Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - Hemo 2017. 2017 ;[citado 2026 abr. 25 ]
Artigo de periodico-carta/editorial
Sézary syndrome with T/NK phenotype: a variant phenotype or a distinct clinical entity ? [Carta] (2017)
Matos, Daniel Mazza; Kaufman, Jacques; Scrideli, Carlos Alberto; Falcão, Roberto Passetto
Source: Cytometry. Part B : Clinical Cytometry. Unidade: FMRP
Subjects: LINFOMA, LINFÓCITOS T, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATOS, Daniel Mazza et al. Sézary syndrome with T/NK phenotype: a variant phenotype or a distinct clinical entity ? [Carta]. Cytometry. Part B : Clinical Cytometry. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/cyto.b.21381. Acesso em: 25 abr. 2026. , 2017
APA
Matos, D. M., Kaufman, J., Scrideli, C. A., & Falcão, R. P. (2017). Sézary syndrome with T/NK phenotype: a variant phenotype or a distinct clinical entity ? [Carta]. Cytometry. Part B : Clinical Cytometry. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/cyto.b.21381
NLM
Matos DM, Kaufman J, Scrideli CA, Falcão RP. Sézary syndrome with T/NK phenotype: a variant phenotype or a distinct clinical entity ? [Carta] [Internet]. Cytometry. Part B : Clinical Cytometry. 2017 ; 94( 4): 561-563.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1002/cyto.b.21381
Vancouver
Matos DM, Kaufman J, Scrideli CA, Falcão RP. Sézary syndrome with T/NK phenotype: a variant phenotype or a distinct clinical entity ? [Carta] [Internet]. Cytometry. Part B : Clinical Cytometry. 2017 ; 94( 4): 561-563.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1002/cyto.b.21381
Artigo de periodico
Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A (2017)
Furtado, Felipe Magalhães; Scheucher, Priscila Santos; Santana, Bárbara Amélia Aparecida; Scatena, Natália Ferreira; Calado, Rodrigo Tocantins; Rego, Eduardo Magalhães; Matos, Daniel Mazza; Falcão, Roberto Passetto
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: LINFÓCITOS B, ESTUDOS DE CASOS E CONTROLES, CITOMETRIA DE FLUXO, LEUCEMIA, TELÔMERO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Felipe Magalhães et al. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A. Brazilian Journal of Medical and Biological Research, v. 50, n. 5, 2017Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20176019. Acesso em: 25 abr. 2026.
APA
Furtado, F. M., Scheucher, P. S., Santana, B. A. A., Scatena, N. F., Calado, R. T., Rego, E. M., et al. (2017). Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A. Brazilian Journal of Medical and Biological Research, 50( 5). doi:10.1590/1414-431x20176019
NLM
Furtado FM, Scheucher PS, Santana BAA, Scatena NF, Calado RT, Rego EM, Matos DM, Falcão RP. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A [Internet]. Brazilian Journal of Medical and Biological Research. 2017 ; 50( 5):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1590/1414-431x20176019
Vancouver
Furtado FM, Scheucher PS, Santana BAA, Scatena NF, Calado RT, Rego EM, Matos DM, Falcão RP. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A [Internet]. Brazilian Journal of Medical and Biological Research. 2017 ; 50( 5):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1590/1414-431x20176019
Artigo de periodico
Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma (2016)
Panero, Julieta; Alves-Paiva, Raquel M.; Roisman, Alejandro; Santana-Lemos, Bárbara Amélia Aparecida; Falcão, Roberto Passetto; Oliveira, Gustavo; Martins, Diego; Stanganelli, Carmen; Slavutsky, Irma; Calado, Rodrigo Tocantins
Source: American Journal of Hematology. Unidade: FMRP
Subjects: LINFOMA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANERO, Julieta et al. Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma. American Journal of Hematology, v. 91, n. 5, p. 481-485, 2016Tradução . . Disponível em: https://doi.org/10.1002/ajh.24324. Acesso em: 25 abr. 2026.
APA
Panero, J., Alves-Paiva, R. M., Roisman, A., Santana-Lemos, B. A. A., Falcão, R. P., Oliveira, G., et al. (2016). Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma. American Journal of Hematology, 91( 5), 481-485. doi:10.1002/ajh.24324
NLM
Panero J, Alves-Paiva RM, Roisman A, Santana-Lemos BAA, Falcão RP, Oliveira G, Martins D, Stanganelli C, Slavutsky I, Calado RT. Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma [Internet]. American Journal of Hematology. 2016 ; 91( 5): 481-485.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1002/ajh.24324
Vancouver
Panero J, Alves-Paiva RM, Roisman A, Santana-Lemos BAA, Falcão RP, Oliveira G, Martins D, Stanganelli C, Slavutsky I, Calado RT. Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma [Internet]. American Journal of Hematology. 2016 ; 91( 5): 481-485.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1002/ajh.24324
Artigo de periodico
Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model (2015)
Assis, Patricia A; Figueiredo-Pontes, Lorena L. de; Lima, Ana Silvia G; Leão, Vitor; Cândido, Larissa A; Pintão, Carolina T; Garcia, Aglair Bergamo; Saggioro, Fabiano Pinto; Panepucci, Rodrigo A; Chahud, Fernando; Nagler, Arnon; Falcão, Roberto Passetto; Rego, Eduardo Magalhaes
Source: Journal of Experimental and Clinical Cancer Research. Unidades: SVOI, FMRP
Subjects: ALCALOIDES, ENDOTÉLIO VASCULAR, LEUCEMIA MIELOIDE, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSIS, Patricia A et al. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. Journal of Experimental and Clinical Cancer Research, v. 34, n. ju, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13046-015-0181-2. Acesso em: 25 abr. 2026.
APA
Assis, P. A., Figueiredo-Pontes, L. L. de, Lima, A. S. G., Leão, V., Cândido, L. A., Pintão, C. T., et al. (2015). Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. Journal of Experimental and Clinical Cancer Research, 34( ju). doi:10.1186/s13046-015-0181-2
NLM
Assis PA, Figueiredo-Pontes LL de, Lima ASG, Leão V, Cândido LA, Pintão CT, Garcia AB, Saggioro FP, Panepucci RA, Chahud F, Nagler A, Falcão RP, Rego EM. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model [Internet]. Journal of Experimental and Clinical Cancer Research. 2015 ; 34( ju):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1186/s13046-015-0181-2
Vancouver
Assis PA, Figueiredo-Pontes LL de, Lima ASG, Leão V, Cândido LA, Pintão CT, Garcia AB, Saggioro FP, Panepucci RA, Chahud F, Nagler A, Falcão RP, Rego EM. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model [Internet]. Journal of Experimental and Clinical Cancer Research. 2015 ; 34( ju):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1186/s13046-015-0181-2
Artigo de periodico
Monoclonal B-cell lymphocytosis in individuals from sporadic (non-familial) chronic lymphocytic leukemia families persists over time, but does not progress to chronic B-cell lymphoproliferative diseases (2015)
Matos, Daniel Mazza; Furtado, Felipe Magalhães; Falcão, Roberto Passetto
Source: Revista Brasileira de Hematologia e Hemoterapia. Unidade: FMRP
Subjects: LINFOMA, LEUCEMIA, CITOMETRIA DE FLUXO, PARENTESCO, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATOS, Daniel Mazza e FURTADO, Felipe Magalhães e FALCÃO, Roberto Passetto. Monoclonal B-cell lymphocytosis in individuals from sporadic (non-familial) chronic lymphocytic leukemia families persists over time, but does not progress to chronic B-cell lymphoproliferative diseases. Revista Brasileira de Hematologia e Hemoterapia, v. 37, n. 5, p. 292-295, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.bjhh.2015.05.006. Acesso em: 25 abr. 2026.
APA
Matos, D. M., Furtado, F. M., & Falcão, R. P. (2015). Monoclonal B-cell lymphocytosis in individuals from sporadic (non-familial) chronic lymphocytic leukemia families persists over time, but does not progress to chronic B-cell lymphoproliferative diseases. Revista Brasileira de Hematologia e Hemoterapia, 37( 5), 292-295. doi:10.1016/j.bjhh.2015.05.006
NLM
Matos DM, Furtado FM, Falcão RP. Monoclonal B-cell lymphocytosis in individuals from sporadic (non-familial) chronic lymphocytic leukemia families persists over time, but does not progress to chronic B-cell lymphoproliferative diseases [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2015 ; 37( 5): 292-295.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.bjhh.2015.05.006
Vancouver
Matos DM, Furtado FM, Falcão RP. Monoclonal B-cell lymphocytosis in individuals from sporadic (non-familial) chronic lymphocytic leukemia families persists over time, but does not progress to chronic B-cell lymphoproliferative diseases [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2015 ; 37( 5): 292-295.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.bjhh.2015.05.006
Artigo de periodico
Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities (2014)
Oliveira, Fábio Morato de; Rodrigues-Alves, Ana Paula Nunes; Lucena-Araújo, Antônio Roberto; Silva, Ferdinando de Paula; Silva, Fernanda Borges da; Falcao, Roberto Passetto
Source: Medical Oncology. Unidade: FMRP
Subjects: LINFOMA (GENÉTICA;METABOLISMO), MAPEAMENTO CROMOSSÔMICO, CROMOSSOMOS HUMANOS, PROTEÍNAS PROTO-ONCOGÊNICAS, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities. Medical Oncology, v. 31, n. 5, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12032-014-0931-6. Acesso em: 25 abr. 2026.
APA
Oliveira, F. M. de, Rodrigues-Alves, A. P. N., Lucena-Araújo, A. R., Silva, F. de P., Silva, F. B. da, & Falcao, R. P. (2014). Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities. Medical Oncology, 31( 5). doi:10.1007/s12032-014-0931-6
NLM
Oliveira FM de, Rodrigues-Alves APN, Lucena-Araújo AR, Silva F de P, Silva FB da, Falcao RP. Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities [Internet]. Medical Oncology. 2014 ; 31( 5):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-014-0931-6
Vancouver
Oliveira FM de, Rodrigues-Alves APN, Lucena-Araújo AR, Silva F de P, Silva FB da, Falcao RP. Mantle cell lymphoma harboring Burkitt’s-like translocations presents differential expression of aurora kinase genes compared with others 8q abnormalities [Internet]. Medical Oncology. 2014 ; 31( 5):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-014-0931-6
Artigo de periodico
Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis (2014)
De Santis, Gil Cunha; Oliveira, Luciana Correa; Ramos, Aline Fernanda; Silva, Nataly Dantas Fortes da; Falcao, Roberto Passetto
Source: Revista Brasileira de Hematologia e Hemoterapia. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, BAÇO (PATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE SANTIS, Gil Cunha et al. Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis. Revista Brasileira de Hematologia e Hemoterapia, v. 36, n. 4, p. 290-292, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.bjhh.2014.05.006. Acesso em: 25 abr. 2026.
APA
De Santis, G. C., Oliveira, L. C., Ramos, A. F., Silva, N. D. F. da, & Falcao, R. P. (2014). Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis. Revista Brasileira de Hematologia e Hemoterapia, 36( 4), 290-292. doi:10.1016/j.bjhh.2014.05.006
NLM
De Santis GC, Oliveira LC, Ramos AF, Silva NDF da, Falcao RP. Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2014 ; 36( 4): 290-292.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.bjhh.2014.05.006
Vancouver
De Santis GC, Oliveira LC, Ramos AF, Silva NDF da, Falcao RP. Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2014 ; 36( 4): 290-292.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.bjhh.2014.05.006
Artigo de periodico
Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH (2013)
Oliveira, Fábio Morato de; Araújo, Antonio Roberto Lucena de; Favarin, Maria do Carmo; Palma, Patricia Vianna Bonini; Rego, Eduardo Magalhães; Falcão, Roberto Passetto; Covas, Dimas Tadeu; Fontes, Aparecida Maria
Source: Experimental Hematology. Unidade: FMRP
Subjects: GENES, HEMATOLOGIA (CITOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH. Experimental Hematology, v. 41, n. 2, p. 198-208, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.exphem.2012.10.009. Acesso em: 25 abr. 2026.
APA
Oliveira, F. M. de, Araújo, A. R. L. de, Favarin, M. do C., Palma, P. V. B., Rego, E. M., Falcão, R. P., et al. (2013). Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH. Experimental Hematology, 41( 2), 198-208. doi:10.1016/j.exphem.2012.10.009
NLM
Oliveira FM de, Araújo ARL de, Favarin M do C, Palma PVB, Rego EM, Falcão RP, Covas DT, Fontes AM. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH [Internet]. Experimental Hematology. 2013 ; 41( 2): 198-208.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.exphem.2012.10.009
Vancouver
Oliveira FM de, Araújo ARL de, Favarin M do C, Palma PVB, Rego EM, Falcão RP, Covas DT, Fontes AM. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH [Internet]. Experimental Hematology. 2013 ; 41( 2): 198-208.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.exphem.2012.10.009
Artigo de periodico
Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia (2013)
Gimenes-Teixeira, Hamilton L.; Lucena-Araújo, Antonio R.; Santos, Guilherme A. dos; Zanette, Dalila L.; Scheucher, Priscila Santos; Oliveira, Luciana C.; Dalmazzo, Leandro F.; Silva Júnior, Wilson Araújo da; Falcão, Roberto Passetto; Rego, Eduardo Magalhães
Source: Experimental Hematology and Oncology. Unidade: FMRP
Subjects: LEUCEMIA, LINFÓCITOS, DOENÇA AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIMENES-TEIXEIRA, Hamilton L. et al. Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia. Experimental Hematology and Oncology, v. 2, 2013Tradução . . Disponível em: https://doi.org/10.1186/2162-3619-2-10. Acesso em: 25 abr. 2026.
APA
Gimenes-Teixeira, H. L., Lucena-Araújo, A. R., Santos, G. A. dos, Zanette, D. L., Scheucher, P. S., Oliveira, L. C., et al. (2013). Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia. Experimental Hematology and Oncology, 2. doi:10.1186/2162-3619-2-10
NLM
Gimenes-Teixeira HL, Lucena-Araújo AR, Santos GA dos, Zanette DL, Scheucher PS, Oliveira LC, Dalmazzo LF, Silva Júnior WA da, Falcão RP, Rego EM. Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia [Internet]. Experimental Hematology and Oncology. 2013 ; 2[citado 2026 abr. 25 ] Available from: https://doi.org/10.1186/2162-3619-2-10
Vancouver
Gimenes-Teixeira HL, Lucena-Araújo AR, Santos GA dos, Zanette DL, Scheucher PS, Oliveira LC, Dalmazzo LF, Silva Júnior WA da, Falcão RP, Rego EM. Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia [Internet]. Experimental Hematology and Oncology. 2013 ; 2[citado 2026 abr. 25 ] Available from: https://doi.org/10.1186/2162-3619-2-10
Artigo de periodico
FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities (2013)
Oliveira, Fábio Morato de; Miguel, Carlos Eduardo; Araújo, Antonio Roberto Lucena; Lima, Ana Silvia Gouvêa de; Falcao, Roberto Passetto; Rego, Eduardo Magalhaes
Source: Medical Oncology. Unidade: FMRP
Subjects: IDOSOS, LEUCEMIA MIELOIDE AGUDA, PROTEÍNAS PROTO-ONCOGÊNICAS, HIBRIDIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities. Medical Oncology, v. 30, n. 1, 2013Tradução . . Disponível em: https://doi.org/10.1007/s12032-013-0483-1. Acesso em: 25 abr. 2026.
APA
Oliveira, F. M. de, Miguel, C. E., Araújo, A. R. L., Lima, A. S. G. de, Falcao, R. P., & Rego, E. M. (2013). FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities. Medical Oncology, 30( 1). doi:10.1007/s12032-013-0483-1
NLM
Oliveira FM de, Miguel CE, Araújo ARL, Lima ASG de, Falcao RP, Rego EM. FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities [Internet]. Medical Oncology. 2013 ; 30( 1):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-013-0483-1
Vancouver
Oliveira FM de, Miguel CE, Araújo ARL, Lima ASG de, Falcao RP, Rego EM. FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities [Internet]. Medical Oncology. 2013 ; 30( 1):[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-013-0483-1
Artigo de periodico
The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets (2012)
Careta, Francisco de Paula; Gobessi, Stefania; Panepucci, Rodrigo Alexandre; Oliveira, Fábio Morato de; Matos, Daniel Mazza; Falcao, Roberto Passetto; Laurenti, Luca; Zago, Marco Antonio; Efremov, Dimitar G.
Source: Haematologica. Unidade: FMRP
Subjects: LEUCEMIA, TERAPÊUTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARETA, Francisco de Paula et al. The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets. Haematologica, v. 97, n. 8, p. 1246-1254, 2012Tradução . . Disponível em: https://doi.org/10.3324/haematol.2011.054668. Acesso em: 25 abr. 2026.
APA
Careta, F. de P., Gobessi, S., Panepucci, R. A., Oliveira, F. M. de, Matos, D. M., Falcao, R. P., et al. (2012). The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets. Haematologica, 97( 8), 1246-1254. doi:10.3324/haematol.2011.054668
NLM
Careta F de P, Gobessi S, Panepucci RA, Oliveira FM de, Matos DM, Falcao RP, Laurenti L, Zago MA, Efremov DG. The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets [Internet]. Haematologica. 2012 ; 97( 8): 1246-1254.[citado 2026 abr. 25 ] Available from: https://doi.org/10.3324/haematol.2011.054668
Vancouver
Careta F de P, Gobessi S, Panepucci RA, Oliveira FM de, Matos DM, Falcao RP, Laurenti L, Zago MA, Efremov DG. The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets [Internet]. Haematologica. 2012 ; 97( 8): 1246-1254.[citado 2026 abr. 25 ] Available from: https://doi.org/10.3324/haematol.2011.054668
Artigo de periodico
Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia (2012)
Lucena-Araujo, Antonio Roberto; Figueiredo-Pontes, Lorena Lobo; Oliveira, Fábio Morato de; Chauffaille, Maria de Lourdes; Falcao, Roberto Passetto; Rego, Eduardo Magalhaes
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCENA-ARAUJO, Antonio Roberto et al. Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia. Medical Oncology, v. 29, n. 2, p. 1114-1118, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-9890-3. Acesso em: 25 abr. 2026.
APA
Lucena-Araujo, A. R., Figueiredo-Pontes, L. L., Oliveira, F. M. de, Chauffaille, M. de L., Falcao, R. P., & Rego, E. M. (2012). Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia. Medical Oncology, 29( 2), 1114-1118. doi:10.1007/s12032-011-9890-3
NLM
Lucena-Araujo AR, Figueiredo-Pontes LL, Oliveira FM de, Chauffaille M de L, Falcao RP, Rego EM. Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1114-1118.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-011-9890-3
Vancouver
Lucena-Araujo AR, Figueiredo-Pontes LL, Oliveira FM de, Chauffaille M de L, Falcao RP, Rego EM. Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1114-1118.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-011-9890-3
Artigo de periodico
Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia (2012)
Jácomo, Rafael H.; Santana-Lemos, Bárbara Amélia Aparecida; Lima, Ana Silvia G.; Assis, Patrícia A.; Lange, Ana Paula A.; Figueiredo-Pontes, Lorena L.; Oliveira, Luciana O.; Bassi, Sarah C.; Benício, Mariana T. L.; Baggio, Márcia S.; Garcia, Aglair Bergamo; Falcão, Roberto Passetto; Rego, Eduardo Magalhães
Source: Blood. Unidade: FMRP
Subjects: LEUCEMIA, COAGULAÇÃO (DIAGNÓSTICO;TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JÁCOMO, Rafael H. et al. Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia. Blood, v. 120, n. 1, p. 207-213, 2012Tradução . . Disponível em: https://doi.org/10.1182/blood-2011-04-347187. Acesso em: 25 abr. 2026.
APA
Jácomo, R. H., Santana-Lemos, B. A. A., Lima, A. S. G., Assis, P. A., Lange, A. P. A., Figueiredo-Pontes, L. L., et al. (2012). Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia. Blood, 120( 1), 207-213. doi:10.1182/blood-2011-04-347187
NLM
Jácomo RH, Santana-Lemos BAA, Lima ASG, Assis PA, Lange APA, Figueiredo-Pontes LL, Oliveira LO, Bassi SC, Benício MTL, Baggio MS, Garcia AB, Falcão RP, Rego EM. Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia [Internet]. Blood. 2012 ; 120( 1): 207-213.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1182/blood-2011-04-347187
Vancouver
Jácomo RH, Santana-Lemos BAA, Lima ASG, Assis PA, Lange APA, Figueiredo-Pontes LL, Oliveira LO, Bassi SC, Benício MTL, Baggio MS, Garcia AB, Falcão RP, Rego EM. Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia [Internet]. Blood. 2012 ; 120( 1): 207-213.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1182/blood-2011-04-347187
Artigo de periodico
Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia (2012)
Oliveira, Fábio Morato de; Pontes, Lorena Lobo de Figueiredo; Bassi, Sarah Cristina; Dalmazzo, Leandro Felipe Figueiredo; Falcao, Roberto Passetto
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia. Medical Oncology, v. 29, n. 2, p. 1227-1230, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-9957-1. Acesso em: 25 abr. 2026.
APA
Oliveira, F. M. de, Pontes, L. L. de F., Bassi, S. C., Dalmazzo, L. F. F., & Falcao, R. P. (2012). Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia. Medical Oncology, 29( 2), 1227-1230. doi:10.1007/s12032-011-9957-1
NLM
Oliveira FM de, Pontes LL de F, Bassi SC, Dalmazzo LFF, Falcao RP. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1227-1230.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-011-9957-1
Vancouver
Oliveira FM de, Pontes LL de F, Bassi SC, Dalmazzo LFF, Falcao RP. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1227-1230.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-011-9957-1
Artigo de periodico
(+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo (2012)
Santos, G. A. S.; Abreu e Lima, R. S.; Pestana, C. R.; Lima, A. S. G.; Scheucher, P. S.; Thomé, C. H.; Gimenes Teixeira, H. L.; Santana-Lemos, Bárbara Amélia Aparecida; Lucena-Araújo, A. R.; Rodrigues, F. P.; Nasr, R.; Uyemura, Sérgio Akira; Falcao, Roberto Passetto; Thé, H. de; Pandolfi, P. P.; Curti, Carlos; Rego, Eduardo Magalhaes
Source: Leukemia. Unidades: FMRP, FCFRP
Subjects: ANTINEOPLÁSICOS (FARMACOLOGIA;APLICAÇÕES TERAPÊUTICAS), ANTIOXIDANTES, APOPTOSE (EFEITOS DE DROGAS), MODELOS ANIMAIS DE DOENÇAS, TRANSPORTE DE ELÉTRONS (ANTAGONISTAS E INIBIDORES), LEUCEMIA, MITOCÔNDRIAS (EFEITOS DE DROGAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, G. A. S. et al. (+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo. Leukemia, v. 26, n. 3, p. 451-460, 2012Tradução . . Disponível em: https://doi.org/10.1038/leu.2011.216. Acesso em: 25 abr. 2026.
APA
Santos, G. A. S., Abreu e Lima, R. S., Pestana, C. R., Lima, A. S. G., Scheucher, P. S., Thomé, C. H., et al. (2012). (+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo. Leukemia, 26( 3), 451-460. doi:10.1038/leu.2011.216
NLM
Santos GAS, Abreu e Lima RS, Pestana CR, Lima ASG, Scheucher PS, Thomé CH, Gimenes Teixeira HL, Santana-Lemos BAA, Lucena-Araújo AR, Rodrigues FP, Nasr R, Uyemura SA, Falcao RP, Thé H de, Pandolfi PP, Curti C, Rego EM. (+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo [Internet]. Leukemia. 2012 ; 26( 3): 451-460.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1038/leu.2011.216
Vancouver
Santos GAS, Abreu e Lima RS, Pestana CR, Lima ASG, Scheucher PS, Thomé CH, Gimenes Teixeira HL, Santana-Lemos BAA, Lucena-Araújo AR, Rodrigues FP, Nasr R, Uyemura SA, Falcao RP, Thé H de, Pandolfi PP, Curti C, Rego EM. (+)'alfa'-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex 1 and is as effective as arsenic trioxide or ATRA against promyelocytic Leukemia in vivo [Internet]. Leukemia. 2012 ; 26( 3): 451-460.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1038/leu.2011.216
Artigo de periodico
Comparative analysis of the pathological events involved in immune and non-immune TRALI models (2012)
Tamarozzi, M. B.; Soares, S. G.; Nunes, Anderson de Sá ; Paiva, H. H.; Saggioro, F. P.; Garcia, A. B.; Lucena-Araujo, A. R.; Falcão, Roberto Passetto; Bordin, J. O.; Rego, Eduardo Magalhães
Source: Vox Sanguinis. Unidades: ICB, FMRP
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAMAROZZI, M. B. et al. Comparative analysis of the pathological events involved in immune and non-immune TRALI models. Vox Sanguinis, v. 103, n. 4, p. 309-321, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1423-0410.2012.01613.x. Acesso em: 25 abr. 2026.
APA
Tamarozzi, M. B., Soares, S. G., Nunes, A. de S., Paiva, H. H., Saggioro, F. P., Garcia, A. B., et al. (2012). Comparative analysis of the pathological events involved in immune and non-immune TRALI models. Vox Sanguinis, 103( 4), 309-321. doi:10.1111/j.1423-0410.2012.01613.x
NLM
Tamarozzi MB, Soares SG, Nunes A de S, Paiva HH, Saggioro FP, Garcia AB, Lucena-Araujo AR, Falcão RP, Bordin JO, Rego EM. Comparative analysis of the pathological events involved in immune and non-immune TRALI models [Internet]. Vox Sanguinis. 2012 ; 103( 4): 309-321.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1111/j.1423-0410.2012.01613.x
Vancouver
Tamarozzi MB, Soares SG, Nunes A de S, Paiva HH, Saggioro FP, Garcia AB, Lucena-Araujo AR, Falcão RP, Bordin JO, Rego EM. Comparative analysis of the pathological events involved in immune and non-immune TRALI models [Internet]. Vox Sanguinis. 2012 ; 103( 4): 309-321.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1111/j.1423-0410.2012.01613.x
Artigo de periodico
A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia (2012)
Oliveira, Fábio Morato de; Palma, Leonardo de Carvalho; Falcao, Roberto Passetto; Simoes, Belinda Pinto
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia. Medical Oncology, v. 29, n. 4, p. 2332-2336, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-0142-3. Acesso em: 25 abr. 2026.
APA
Oliveira, F. M. de, Palma, L. de C., Falcao, R. P., & Simoes, B. P. (2012). A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia. Medical Oncology, 29( 4), 2332-2336. doi:10.1007/s12032-011-0142-3
NLM
Oliveira FM de, Palma L de C, Falcao RP, Simoes BP. A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia [Internet]. Medical Oncology. 2012 ; 29( 4): 2332-2336.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-011-0142-3
Vancouver
Oliveira FM de, Palma L de C, Falcao RP, Simoes BP. A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia [Internet]. Medical Oncology. 2012 ; 29( 4): 2332-2336.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s12032-011-0142-3
Artigo de periodico
Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups (2012)
Gadji, Macoura; Awe, Julius Adebayo; Rodrigues, Prerana; Kumar, Rajat; Houston, Donald S.; Klewes, Ludger; Dièye, Tandakha Ndiaye; Rego, Eduardo Magalhães; Passetto, Roberto Falcão; Oliveira, Fábio Morato de; Mai, Sabine
Source: Clinical Cancer Research. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, MEDULA ÓSSEA, NÚCLEO CELULAR, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GADJI, Macoura et al. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clinical Cancer Research, v. 18, n. 12, p. 3293-3304, 2012Tradução . . Disponível em: https://doi.org/10.1158/1078-0432.CCR-12-0087. Acesso em: 25 abr. 2026.
APA
Gadji, M., Awe, J. A., Rodrigues, P., Kumar, R., Houston, D. S., Klewes, L., et al. (2012). Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clinical Cancer Research, 18( 12), 3293-3304. doi:10.1158/1078-0432.CCR-12-0087
NLM
Gadji M, Awe JA, Rodrigues P, Kumar R, Houston DS, Klewes L, Dièye TN, Rego EM, Passetto RF, Oliveira FM de, Mai S. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups [Internet]. Clinical Cancer Research. 2012 ; 18( 12): 3293-3304.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1158/1078-0432.CCR-12-0087
Vancouver
Gadji M, Awe JA, Rodrigues P, Kumar R, Houston DS, Klewes L, Dièye TN, Rego EM, Passetto RF, Oliveira FM de, Mai S. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups [Internet]. Clinical Cancer Research. 2012 ; 18( 12): 3293-3304.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1158/1078-0432.CCR-12-0087

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Indexado em

Normalized affiliation

Non normalized affiliation